tradingkey.logo
tradingkey.logo
Suchen

Insulet Corp

PODD
Zur Watchlist hinzufügen
156.270USD
-1.470-0.93%
Trading geöffnet ETKurse um 15 Minuten verzögert
10.82BMarktkapitalisierung
36.25KGV TTM

mehr Informationen über Insulet Corp Unternehmen

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Insulet Corp Informationen

BörsenkürzelPODD
Name des UnternehmensInsulet Corp
IPO-datumMay 15, 2007
CEOMcevoy (Ashley)
Anzahl der mitarbeiter3900
WertpapierartOrdinary Share
GeschäftsjahresendeMay 15
Addresse100 Nagog Park
StadtACTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01720-3440
Telefon19786007000
Websitehttps://www.omnipod.com
BörsenkürzelPODD
IPO-datumMay 15, 2007
CEOMcevoy (Ashley)

Führungskräfte von Insulet Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
29.36K
+5.65%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
19.92K
+8.33%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
10.35K
+33.33%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
8.67K
+32.17%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
5.36K
+35.90%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.55K
-11.77%
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.11K
-123.87%
Dr. Wayne A.I. Frederick, M.D.
Dr. Wayne A.I. Frederick, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
29.36K
+5.65%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
19.92K
+8.33%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
10.35K
+33.33%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
8.67K
+32.17%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Insulet Corp?

Die fünf größten Anteilseigner von Insulet Corp sind: Dr. Jessica Hopfield, Ph.D.

Wie viele Institutionen halten Anteile an Insulet Corp (PODD)?

Mit Stand vom 2026Q1 halten 1624 Institutionen Anteile an Insulet Corp, mit einem Gesamtmarktwert von etwa 73.18M, was 105.65% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1617450.00 gestiegen.

Was ist die größte Einnahmequelle von Insulet Corp?

Am 2026Q1 erzielte das Geschäft mit U.S.Omnipod für Insulet Corp den höchsten Umsatz in Höhe von 1.92B, was 70.89% des Gesamtumsatzes entspricht.
KeyAI